EMQCX
Price
$10.44
Change
-$0.00 (-0.00%)
Updated
Jun 22 closing price
Net Assets
5.82M
VEMIX
Price
$37.45
Change
-$1.10 (-2.85%)
Updated
Jun 23 closing price
Net Assets
162.82B
Interact to see
Advertisement

EMQCX vs VEMIX

EMQCX vs VEMIX Comparison Chart in %
View a ticker or compare two or three
VS
EMQCX vs. VEMIX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMQCX is a Hold and VEMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 163B vs. EMQCX (5.82M). EMQCX pays higher dividends than VEMIX: EMQCX (4.13) vs VEMIX (2.42). EMQCX was incepted earlier than VEMIX: EMQCX (10 years) vs VEMIX (26 years). EMQCX (3.00) is less costly to investors than VEMIX (0.06). EMQCX is a more actively managed with annual turnover of: 209.00 vs. VEMIX (6.00). EMQCX has a lower initial minimum investment than VEMIX: EMQCX (1000) vs VEMIX (5000000). EMQCX annual gain was more profitable for investors over the last year : 32.50 vs. VEMIX (29.97). VEMIX return over 5 years is better than : 25.20 vs. EMQCX (-14.14).
EMQCXVEMIXEMQCX / VEMIX
Total Expense Ratio2.020.063,367%
Annual Report Gross Expense Ratio3.000.065,000%
Fund Existence10 years26 years-
Gain YTD12.62113.73892%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.82M163B0%
Annual Yield % from dividends4.132.42171%
Returns for 1 year32.5029.97108%
Returns for 3 years62.1461.65101%
Returns for 5 years-14.1425.20-56%
Returns for 10 yearsN/A114.98-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QKACX54.58N/A
N/A
Federated Hermes MDT All Cap Core R6
OIEIX27.08N/A
N/A
JPMorgan Equity Income A
TSLAX6.24N/A
N/A
Transamerica Small Cap Value A
MSCMX16.53N/A
N/A
Morgan Stanley Insight C
TGRHX7.28N/A
N/A
Transamerica International Focus A